Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1244593.RArFSrcK-5diK5PaoCuBtLod2Xo0WDftTpJLGsr3Pz3gQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1244593.RArFSrcK-5diK5PaoCuBtLod2Xo0WDftTpJLGsr3Pz3gQ130_assertion type Assertion NP1244593.RArFSrcK-5diK5PaoCuBtLod2Xo0WDftTpJLGsr3Pz3gQ130_head.
- NP1244593.RArFSrcK-5diK5PaoCuBtLod2Xo0WDftTpJLGsr3Pz3gQ130_assertion description "[We investigated risk association of FAS (-1377 G>A and -670 A>G) and FASL (-844 T>C) promoter polymorphisms with breast, ovarian, cervical, and endometrial cancers and report that the FASL -844 CC genotype was protective against breast, ovarian, cervical, and endometrial cancers (P???0.01).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244593.RArFSrcK-5diK5PaoCuBtLod2Xo0WDftTpJLGsr3Pz3gQ130_provenance.
- NP1244593.RArFSrcK-5diK5PaoCuBtLod2Xo0WDftTpJLGsr3Pz3gQ130_assertion evidence source_evidence_literature NP1244593.RArFSrcK-5diK5PaoCuBtLod2Xo0WDftTpJLGsr3Pz3gQ130_provenance.
- NP1244593.RArFSrcK-5diK5PaoCuBtLod2Xo0WDftTpJLGsr3Pz3gQ130_assertion SIO_000772 25472583 NP1244593.RArFSrcK-5diK5PaoCuBtLod2Xo0WDftTpJLGsr3Pz3gQ130_provenance.
- NP1244593.RArFSrcK-5diK5PaoCuBtLod2Xo0WDftTpJLGsr3Pz3gQ130_assertion wasDerivedFrom befree-2016 NP1244593.RArFSrcK-5diK5PaoCuBtLod2Xo0WDftTpJLGsr3Pz3gQ130_provenance.
- NP1244593.RArFSrcK-5diK5PaoCuBtLod2Xo0WDftTpJLGsr3Pz3gQ130_assertion wasGeneratedBy ECO_0000203 NP1244593.RArFSrcK-5diK5PaoCuBtLod2Xo0WDftTpJLGsr3Pz3gQ130_provenance.